Stock Events

Stock Events

Xencor 

$27.51
9
-$0.01-0.04% 08:47 Today

Statistics

Day High
27.57
Day Low
27.5
52W High
27.59
52W Low
7.13
Volume
107,130
Avg. Volume
-
Mkt Cap
2.05B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.71
-1.17
-0.62
-0.08
Expected EPS
-0.314942
Actual EPS
N/A

Financials

-73.2%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
125.58MRevenue
-91.92MNet Income

Analyst Ratings

27.00Average Price Target
The highest estimate is 44.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XNCR. It's not an investment recommendation.
NVIDIA
4
NVDA
Broadcom
4
AVGO
ExxonMobil
4
XOM
Microsoft
3
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes in the biotechnology field, focusing on monoclonal antibodies, a core area of Xencor's technology platform.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm with a strong emphasis on innovative therapeutics, including biologics, which competes directly with Xencor's antibody engineering technologies.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics, overlapping with Xencor's focus areas, especially in oncology and inflammatory diseases.
Biogen
BIIB
Mkt Cap31B
Biogen focuses on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases, competing with Xencor in the biologic drug market.
Incyte
INCY
Mkt Cap24.36B
Incyte Corporation specializes in oncology and inflammation, directly competing with Xencor's pipeline of monoclonal antibodies and cytokine therapeutics.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Xencor in the area of innovative drug development.
Repligen
RGEN
Mkt Cap9.42B
Repligen Corporation provides bioprocessing technologies and solutions, indirectly competing with Xencor by supporting the production of biologic drugs.
Novavax
NVAX
Mkt Cap1.33B
Novavax, Inc. is involved in the development of vaccines and vaccine adjuvants, which represents a competitive area for Xencor's technology in enhancing immune responses.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is a global pharmaceutical corporation with a broad portfolio that includes biopharmaceutical products, competing across several of Xencor's therapeutic areas.

About

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Show more...
CEO
Bassil I. Dahiyat
Employees
260
Country
United States
ISIN
US98401F1057
WKN
000A1W96L

Listings

MU
DE
XE9.MU
STU
DE
XE9.STU
F
DE
XE9.F
XNAS
US
XNCR

0 Comments

Share your thoughts

FAQ

What is Xencor stock price today?▼
The current price of XNCR is $27.51 USD — it has decreased by -0.04% in the past 24 hours. Watch Xencor stock price performance more closely on the chart.
What is Xencor stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Xencor stocks are traded under the ticker XNCR.
Is Xencor stock price growing?▼
XNCR stock has risen by +19.7% compared to the previous week, the month change is a +46.31% rise, over the last year Xencor has showed a +266.44% increase.
What is Xencor market cap?▼
Today Xencor has the market capitalization of 2.05B
When is the next Xencor earnings date?▼
Xencor is going to release the next earnings report on November 09, 2026.
What were Xencor earnings last quarter?▼
XNCR earnings for the last quarter are -0.29 USD per share, whereas the estimation was -0.8 USD resulting in a +63.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xencor revenue for the last year?▼
Xencor revenue for the last year amounts to 125.58M USD.
What is Xencor net income for the last year?▼
XNCR net income for the last year is -91.92M USD.
How many employees does Xencor have?▼
As of August 20, 2026, the company has 260 employees.
In which sector is Xencor located?▼
Xencor operates in the Health & Wellness sector.
When did Xencor complete a stock split?▼
Xencor has not had any recent stock splits.
Where is Xencor headquartered?▼
Xencor is headquartered in PASADENA, United States.